Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

NICE Rejects Javlor, But Could Products For Unmet Clinical Needs Be Rethought?

Related Content

UK's New Cancer Drug Fund Might Not Alleviate Regional Access Disparities

Nov 01 2010

Roche To Appeal NICE's Rejection Of Herceptin For HER2-positive Stomach Cancer

Jul 06 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window